ANZCTR newsletters

View our newsletters here.

Article published in MJA: Australian clinical trial activity and burden of disease: an analysis of registered trials in National Health Priority Areas

Link to article in the Medical Journal of Australia. View here
Link to commentary in MJA InSight. View here

Government website ( sees clinical trial doors open for patients

Link to article in The Australian. View here
Link to Joint Media Release by Minister for Health Sussan Ley and Minister for Industry and Science Ian Macfarlane. View here

The ANZCTR registers its 10,000th trial

This major milestone was reached in November 2014. More...

Registration as a tool to increase research value

This article, published in the Lancet, advocates trial registration as a tool to increase research value. More...

Trial registration now a condition for ethical approval in the UK

Ian Chalmers discusses this significant milestone in his BMJ editorial. More...

Testing transparency

An international movement to boost transparency in clinical trials is gathering momentum. Iain Chalmers, who has championed these issues for many years, talks to Fiona Fleck. More...

Registration requirement for project grant applications

As announced in section 6.3 of the "NHMRC Project Grants Funding Policy" for 2012, all NHMRC funded clinical trials must be registered in the Australian New Zealand Clinical Trials Registry (ANZCTR), or equivalent, prior to commencement of the clinical phase.

Australian Cancer Trials

The Australian Cancer Trials website ( was launched in November 2010, containing information on cancer clinical trials with a recruitment site in Australia, uploaded on a regular basis from the ANZCTR and databases. The website is designed for and aimed towards the Australian consumer, by making clinical trials information more accessible for patients and their healthcare teams, and also in helping facilitate participation in these studies.

Articles of interest

BMJ Editorial: All trials must be registered and the results published.

Biggest cancer killers lack adequate research

Adding value to clinical trial registries: insights from Australian Cancer Trials Online, a website for consumers.

Landscape of cancer clinical trials in Australia: using trial registries to guide future research.

Quality of Registration of Clinical Trials

Trials registration now part of the revised CONSORT statement

ANZCTR has met the requirements of the ICMJE's trials registration policy and is now an ICMJE acceptable registry. More...

Issues in the Registration of Clinical Trials [JAMA 297(19); 2112-2120, 2007] More...

US legislation developments: In March 2007, US Congress Representatives Henry A. Waxman and Edward J. Markey introduced counterpart legislation to the Enzi-Kennedy US Senate bill which intends to further enhance the proposed mandatory clinical trial registry and results database. More...

WHO establishes an International Clinical Trials Registry Platform (ICTRP)

The World Health Organisation (WHO) held a consensus meeting in New York in October 2004 that brought together government research institutions, pharmaceutical industry representatives, journal editors, researchers, and other leading experts to identify substantial common ground regarding trial registration. A general consensus was reached regarding the need for worldwide clinical trial registration. The so called "New York Statement 2004" noted the following:

The need for a global approach to clinical trials registration

  • Trials unambiguously identified
  • Consensus needed on which trials; data; timing and disclosure of results
  • One-stop search portal; publicly available
  • System is simple, effective, efficient
  • Capacity built where appropriate

The ICTRP can be accessed via: to develop an international, electronic search portal through which registries around the world can be located and accessed. This search portal became functional in May 2007. A second objective of the ICTRP is to establish processes for recognising registers of certain standards as Primary Registers. There are also plans for the development of a worldwide unique trial ID numbering system.